Epithelial-mesenchymal transition markers and HER3 expression are predictors of elisidepsin treatment response in breast and pancreatic cancer cell lines.

Teixidó C, Marés R, Aracil M, Ramón y Cajal S, Hernández-Losa J

Open source

DOI
10.1371/journal.pone.0053645
Published
2013
Container
PloS one
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1371/journal.pone.0053645,
  title = {Epithelial-mesenchymal transition markers and HER3 expression are predictors of elisidepsin treatment response in breast and pancreatic cancer cell lines.},
  author = {Teixidó C and Marés R and Aracil M and Ramón y Cajal S and Hernández-Losa J},
  year = {2013},
  journal = {PloS one},
  doi = {10.1371/journal.pone.0053645},
  url = {https://doi.org/10.1371/journal.pone.0053645}
}

RIS

TY  - JOUR
TI  - Epithelial-mesenchymal transition markers and HER3 expression are predictors of elisidepsin treatment response in breast and pancreatic cancer cell lines.
AU  - Teixidó C
AU  - Marés R
AU  - Aracil M
AU  - Ramón y Cajal S
AU  - Hernández-Losa J
PY  - 2013
JO  - PloS one
DO  - 10.1371/journal.pone.0053645
UR  - https://doi.org/10.1371/journal.pone.0053645
ER  - 

APA

C, T., R, M., M, A., S, R. Y. C., & J, H. (2013). Epithelial-mesenchymal transition markers and HER3 expression are predictors of elisidepsin treatment response in breast and pancreatic cancer cell lines.. PloS one. https://doi.org/10.1371/journal.pone.0053645

Source records